In this episode, Dr. Arjun Sahgal, an international clinical and research leader in the field of high-precision stereotactic radiation to the brain and spine for both metastases and primary tumors, as well as oligometastases and the chief of radiation oncology at Sunnybrook Health Sciences Centre’s Odette Cancer Centre, shares his excitement around the initial results of the UNITED (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma) trial. UNITED is the world’s first adaptive MR-guided radiotherapy study for patients with high-grade gliomas, the most common and aggressive primary brain tumors found in adults, and the highlight of his illustrious career so far.

Dr. Sahgal has made challenging the dogma and changing the standard of care for patients whose cancer is considered “incurable” his trademark. But what inspires him? Tune in to episode 2 of Spilling the RT to find out.

Given the huge and increasing incidence of prostate cancer worldwide, enhancing the efficacy, safety and quality of prostate radiation therapy for men is crucial.

In this episode, Dr. Alison Tree, a clinical consultant oncologist who specializes in radiotherapy and chemotherapy for prostate cancer at the Royal Marsden Hospital NHS Foundation Trust, shares the different tools in her toolbox she uses to treat prostate patients. She also discusses why she chose the profession and the rationale around her belief that the future of prostate RT lies in fewer hospital visits, higher doses, and, with growing evidence, better patient experience.